Eckert & Ziegler SE
DUS:EUZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eckert & Ziegler SE
DUS:EUZ
|
DE |
|
T
|
Tompkins Financial Corp
AMEX:TMP
|
US |
|
V
|
Vinci SA
F:SQUA
|
FR |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
Microstrategy Inc
BMV:MSTR
|
US |
|
Time Out Group PLC
F:05T
|
UK |
|
Bank of China Ltd
F:W8VS
|
CN |
|
S
|
SoftBank Group Corp
XMUN:SFT
|
JP |
|
N
|
Nokia Oyj
PSE:NOKIA
|
FI |
Intrinsic Value
Is EUZ undervalued or overvalued?
See the intrinsic value estimate for 
Eckert & Ziegler SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Eckert & Ziegler Does
Eckert & Ziegler Strahlen und Medizintechnik makes radioactive components and radiation-based products used in medicine, research, and industry. Its core business includes sealed radiation sources, calibration standards, brachytherapy seeds, and radioisotope materials that help doctors diagnose and treat disease and help labs and equipment makers measure radiation correctly.
- Headquarters
- Germany DE
- Employees
- 1 100
- IPO date
- May 25, 1999
Eckert & Ziegler has no economic moat
Eckert & Ziegler SE lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Eckert & Ziegler SE
Earnings Waterfall
Eckert & Ziegler SE
The intrinsic value for Eckert & Ziegler SE (EUZ) under the Base Case is hidden EUR.
Compared with the current market price of 13.28 EUR, the stock appears hidden.
